Drug · DIN 02385562
SUMATRIPTAN DF
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since June 1, 2023.
- Drug Identification Number (DIN)
- 02385562
- Company (DIN owner)
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Sumatriptan N02CC01
- Class
- Human
- Record last updated
- September 5, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SUMATRIPTAN (SUMATRIPTAN SUCCINATE) | 25 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 1, 2023: NOC 30909Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement Between Two Manufacturers. Update to the Product Monograph and Package Insert
- May 31, 2012: NOC 13321Abbreviated New Drug Submission (ANDS) · New manufacturer and product name
Other DINs named SUMATRIPTAN DF
- DIN 02385570 · Marketed
- DIN 02385589 · Marketed